Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Digital
ClouDr Partners with Shaanxi Pharmaceutical Firms for Integrated Healthcare Solutions
January 24, 2025
Company
Deals
Syneos Health Partners with Fosun Pharma to Commercialize Serplulimab in US
January 24, 2025
Company
Drug
Sanofi’s iGlarLixi Approved in China for Type 2 Diabetes Management
January 24, 2025
Company
Drug
Roche’s Polivy Approved by China’s NMPA for Lymphoma Treatment
January 25, 2025
Policy / Regulatory
China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs
January 25, 2025
Company
Med Vision Secures A+ Round Financing to Accelerate Digital Therapy Commercialization
November 17, 2024
Company
Drug
MSD China to Take Legal Action Against Market Infringement of Molnupiravir
January 25, 2025
Company
Deals
Med Vision Secures Series A+ Funding to Expand Digital Therapy Portfolio
January 25, 2025
Company
Drug
Kexing Pharmaceutical Initiates Phase I Trial for IFN-Alpha-1b Inhalation Solution
February 12, 2025
Company
Deals
Bioantibody Bio Raises RMB 100 Million in Series A Funding Round
January 25, 2025
Company
Deals
Meihua Partners with Getein Biotech to Manufacture COVID-19 Antigen Tests
January 25, 2025
Company
Drug
CSPC’s Cleviprex Approved for Clinical Study by China’s NMPA
January 25, 2025
1
2
…
1,050
1,051
1,052
1,053
1,054
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?